The Largest Companies in Pharmacy Services & Retail Drugstore Industry Value and Market Capitalization, Revenue, Income, Number of Employees - CSIMarket
Retail Sector

The Largest Companies in Pharmacy Services & Retail Drugstore Industry

Explore the largest companies by market capitalization, revenue, income, and employees within the Pharmacy Services & Retail Drugstore industry

Classification: SIC NAICS ISIC Available under Commercial License
TTM data as of: September 28, 2026
Total Market Cap
$ 344B
Billions USD (aggregate)
Total Revenue (TTM)
$ 1,571B
Trailing twelve months
Total Net Income (TTM)
$ 6B
Trailing twelve months
Total Employees
1,303,169
Headcount (aggregate)
API endpoints for this dataset
https://api.csimarket.com/api/v1/industries/1304/list
Programmatic access for models, analytics, and integration workflows.

Explore the largest companies by market capitalization, revenue, income, and employees within the Pharmacy Services & Retail Drugstore industry

Company Market Cap
(Millions)
Revenue TTM
(Millions)
Net Income TTM
(Millions)
Employees
Total Pharmacy Services & Retail Drugstore Industry $ 343,601 $ 1,571,452 $ 6,220 1,303,169
16 more companies available

Sign in to unlock the full Pharmacy Services & Retail Drugstore Industry dataset.

Industry Benchmarking Dataset for Institutional Use

Commercial

The data presented above is part of our institutional-grade Industry Benchmarking Dataset, designed for integration into credit risk models, AML/KYC frameworks, portfolio analytics, and internal banking systems. The full dataset is available under a Commercial License, with delivery via API or bulk CSV datasets.

Advanced Metrics & Analytics
  • Multi-year CAGRs & growth acceleration signals
  • Volatility measures & trend stability indicators
  • Cross-sectional percentiles (median, p25, p75)
  • Dispersion metrics (std deviation, spread)
  • Composite scores (growth quality, distress risk)
Institutional Use Cases
  • Credit underwriting & peer benchmarking
  • AML / KYC financial validation
  • Portfolio monitoring & risk tracking
  • Quantitative modeling & factor construction
  • Sector risk & supply chain exposure analysis
Data Delivery
API Access
Real-time endpoints delivering data into risk engines, models, and internal systems.
Bulk CSV Datasets
Pre-structured datasets optimized for direct ingestion into data warehouses, enabling large-scale modeling, backtesting, and historical analysis.
Licensing
Available under institution-grade licensing frameworks with defined usage rights, distribution scope, and integration permissions, supporting internal use, client reporting, and enterprise-wide deployment.
CSIMarket - Industry Benchmarking Data - Per Industry

Institutional-grade industry datasets
in standardized CSV format

Pre-cleaned, audit-ready benchmarking data for this industry - 6 CSV files covering profitability, growth, valuation, efficiency, management effectiveness, and financial strength. Each file delivers 20 quarters and 5 fiscal years of history, with statistical distributions and composite scores per period.

6CSV files
3,880Quarterly endpoints
360Annual endpoints
20Quarters of history
5Fiscal years
Profitability
37 quarterly - 10 annual indicators 790 endpoints ?
Growth
31 quarterly - 7 annual indicators 1,455 endpoints ?
Valuation
29 quarterly - 10 annual indicators 630 endpoints ?
Efficiency
16 quarterly - 12 annual indicators 380 endpoints ?
Management
20 quarterly - 16 annual indicators 480 endpoints ?
Fin. Strength
21 quarterly - 17 annual indicators 505 endpoints ?
Total dataset size - across 110 industries
Quarterly data points
388,000
3,880 × 110 industries
Annual data points
36,000
360 × 110 industries
Industries covered
110
all sectors
Total data points
424,000
quarterly + annual
Industry classification systems supported
CSIMarket Proprietary classification optimized for financial benchmarking and industry analytics
NAICS North American Industry Classification System - used by U.S., Canada & Mexico federal agencies
SIC Standard Industrial Classification - legacy system used by the SEC and financial regulators
ISIC International Standard Industrial Classification - UN framework for global economic comparison
Dataset 1 - Profitability Benchmarks

Margin benchmarks across the full industry distribution

Gross, operating, EBITDA, pre-tax, net, and free cash flow margins - delivered as TTM, quarterly, and annual series with P25 / median / P75 / standard deviation for every reporting period.

Net margin (TTM Q4)
7.44%
+2.11pp vs prior yr
Gross margin
10.44%
industry avg
FCF margin
13.66%
strong
Companies reported
31
Q4 2025
Data coverage per industry
Quarterly indicators
37
metrics per period
Annual indicators
10
fiscal year metrics
Quarterly endpoints
740
20 quarters × 37
Annual endpoints
50
5 fiscal years × 10
Gross, operating, EBITDA, net & FCF margins
TTM, quarterly & fiscal year series
P25 / median / P75 / std dev per period
YoY margin change & acceleration
Effective tax rate & pre-tax margin
Profitability composite score (0–100)
Report preview - Profitability Benchmarks - Aerospace & Defense
Profitability Benchmarks report sample
Dataset 2 - Growth Dynamics

Revenue, income & cash flow growth across 13+ line items

Industry-level growth benchmarks for every major P&L and cash flow line - with breadth indicators showing what share of companies posted positive growth, acceleration metrics, and rolling TTM comparisons.

Revenue growth (TTM Q4)
12.84%
improving
Net income growth
18.45%
above revenue
FCF growth
13.60%
strong
EPS acceleration
+3.69pp
vs prior TTM
Data coverage per industry
Quarterly indicators
31
metrics per period
Annual indicators
7
fiscal year metrics
Quarterly endpoints
1,420
20 quarters × 31
Annual endpoints
35
5 fiscal years × 7
Revenue, gross, EBIT & operating income growth
Net income, EPS (basic & diluted) growth
FCF, net cash flow & CapEx growth
Breadth: % of companies with positive growth
QoQ, YoY, TTM & 3-year CAGR
Growth composite score (0–100)
Report preview - Growth Dynamics - Aerospace & Defense
Growth Dynamics report sample
Dataset 3 - Valuation Multiples

Industry valuation multiples with 5-year context & Z-scores

P/E, P/S, P/FCF, P/Book, EV/EBITDA - current and trailing - with five-year averages, percentile ranks, Z-scores, and a composite valuation score to place the industry in historical context.

P/E ratio (current)
22.4x
vs 5yr avg 14.2x
EV/EBITDA (TTM)
13.1x
P25–P75: 4.5x–20.4x
Earnings yield
4.46%
attractive
Composite val. score
61.7
moderately valued
Data coverage per industry
Quarterly indicators
29
metrics per period
Annual indicators
10
fiscal year metrics
Quarterly endpoints
580
20 quarters × 29
Annual endpoints
50
5 fiscal years × 10
P/E, P/S, P/CF, P/FCF, P/Book multiples
EV/EBITDA & EV/Sales (current & TTM)
5-year historical average per multiple
Z-scores & percentile ranks
Earnings yield & FCF yield
Composite valuation score (0–100)
Report preview - Valuation Multiples - Aerospace & Defense
Valuation Multiples report sample
Dataset 4 - Operational Efficiency

Productivity, turnover ratios & cash conversion benchmarks

Revenue and income per employee, asset and receivables turnover, days sales outstanding, days inventory, days payables, and the full cash conversion cycle - benchmarked across the industry distribution.

Revenue / employee
$487K
improving
Asset turnover
0.61x
P75: 0.80x
Cash conv. cycle
113 days
above avg
Efficiency score
68.7
composite 0–100
Data coverage per industry
Quarterly indicators
16
metrics per period
Annual indicators
12
fiscal year metrics
Quarterly endpoints
320
20 quarters × 16
Annual endpoints
60
5 fiscal years × 12
Revenue & net income per employee
Asset, receivables & inventory turnover
DSO, DIO, DPO & cash conversion cycle
Working capital per revenue
YoY & TTM trend for all metrics
Efficiency composite score (0–100)
Report preview - Operational Efficiency - Aerospace & Defense
Operational Efficiency report sample
Dataset 5 - Management Effectiveness

ROA, ROE, ROIC & DuPont decomposition benchmarks

Return metrics measuring how effectively management allocates capital - with incremental ROIC, DuPont decomposition, FCF quality indicators, and a composite management effectiveness score across the industry.

Return on assets
5.05%
vs 4.44% prior
Return on equity
14.22%
improving
ROIC (TTM)
9.77%
P75: 12.4%
Effectiveness score
72.4
composite index
Data coverage per industry
Quarterly indicators
20
metrics per period
Annual indicators
16
fiscal year metrics
Quarterly endpoints
400
20 quarters × 20
Annual endpoints
80
5 fiscal years × 16
ROA, ROE & ROIC - TTM & quarterly
Incremental ROIC & capital intensity
DuPont 3-factor decomposition
FCF conversion quality metrics
P25 / median / P75 / std dev per metric
Management effectiveness composite (0–100)
Report preview - Management Effectiveness - Aerospace & Defense
Management Effectiveness report sample
Dataset 6 - Financial Strength

Leverage, liquidity & debt coverage across the industry

Debt-to-equity, interest and debt coverage, quick ratio, working capital, leverage ratios - full distribution statistics - in standardized, audit-ready format suited for credit workflows, compliance, and ESG reporting.

Debt / equity (TTM)
1.44x
above industry avg
Interest coverage
8.32x
comfortable
Quick ratio
0.91x
vs P75 1.18x
Fin. strength score
58.4
composite 0–100
Data coverage per industry
Quarterly indicators
21
metrics per period
Annual indicators
17
fiscal year metrics
Quarterly endpoints
420
20 quarters × 21
Annual endpoints
85
5 fiscal years × 17
Quick ratio & working capital ratio
Total & LT debt-to-equity
Leverage & tangible leverage ratios
Interest & debt coverage ratios
P25 / median / P75 / std dev per metric
Financial strength composite score (0–100)
Report preview - Financial Strength - Aerospace & Defense
Financial Strength report sample
Methodology
1. Data Coverage & Universe
Structured dataset built from publicly listed companies, classified across industries, sectors, and total market using CSIMarket, NAICS, SIC, and ISIC frameworks.

Includes up to 5 years of quarterly data (TTM, quarterly, annualized) with continuous updates during earnings cycles.

Coverage transparency includes total companies, reported companies per metric, and coverage ratios.
2. Aggregation Methodology
Industry metrics are calculated using aggregated financial statements, not averages.

Sum-based aggregation is applied to revenue, income, assets, and debt, with market-cap weighting for valuation metrics and TTM normalization to reduce seasonality.

Example: P/E = Total Market Cap ÷ Total Net Income.
3. Ratio Construction
Ratios are standardized and calculated at the company level, then benchmarked across industries.

Covers profitability, valuation, financial strength, efficiency, and growth metrics including margins, ROE, EV multiples, leverage ratios, and CAGR growth measures.
4. Distribution Analytics
Full cross-sectional distribution analysis includes median (P50), quartiles (P25/P75), standard deviation, and interquartile range.

Enables detection of outliers, dispersion, and structural differences within industries.
5. Percentile Rankings
Metrics are normalized into 0–100 percentile rankings using cross-industry PERCENT_RANK().

Direction is adjusted by metric (higher = better for growth/profitability, lower = better for leverage/risk).

Used for benchmarking, factor models, and relative analysis.
6. Volatility & Trend Metrics
Includes volatility (e.g., 8-quarter standard deviation), trend slopes, and growth consistency metrics.

Captures earnings stability, margin durability, and cyclicality across industries.
7. Composite Scores
Multi-factor composite scores (0-100 scale) combine normalized inputs using weighted models.

Includes valuation, growth quality, financial strength, and distress risk scores.
8. Data Quality Controls
Data undergoes standardization, outlier detection, consistency checks, and coverage-based filtering.

Reporting counts and coverage ratios are provided for transparency.
9. Update Frequency
Dataset is continuously updated during earnings seasons.

TTM metrics are recalculated with each new filing, reflecting the most recent reported data.
10. Use Cases
Designed for credit risk analysis, AML/KYC validation, portfolio monitoring, quantitative modeling, and benchmarking workflows.
11. Licensing & Access
Free preview available for evaluation. Full dataset access requires a commercial license.

API and bulk delivery options available for system integration.

Recent News from The Largest Companies in Pharmacy Services & Retail Drugstore Industry

Product Service News
Cosmos Healths $2 Million Ethereum Bet Pioneering Blockchain Integration in Healthcare,

Harnessing Blockchain: Cosmos Health s Strategic Investment in Ethereum In a bold move reflecting both financial acumen and visionary foresight, Cosmos Health Inc., a pioneering force in the global healthcare landscape, has further entrenched itself in the world of digital assets. On October 21, 2025, the company announced the acquisition of an additional...

Oct 21, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Business Update
Herbalife Balancing Acclaim with Collection Challenges in a Competitive Market,

In a competitive market, brands must navigate a myriad of operational challenges while simultaneously managing their reputation and fiscal health. Herbalife Ltd, a global leader in nutritional supplements, has found itself in the limelight after being named to Forbes inaugural list of America s Best Brands for Value. However, this accolade comes with its...

Oct 14, 2025 • Pharmacy Services and Retail Drugstore Industry
HLF
Business Update
Herbalife Ltd. Amid Recognition and Receivables Challenges A Dual Financial Narrative,

Herbalife Ltd., a prominent player in the global nutrition industry, was recently named to Forbes inaugural list of America s Best Brands for Value. This recognition is a standout achievement for the company, reflecting its brand strength and market presence. However, the company also faces challenges related to its accounts receivable management, sugges...

Oct 14, 2025 • Pharmacy Services and Retail Drugstore Industry
HLF
Product Service News
Cosmos Health Embarks on U.S. Nutraceuticals Journey with Ambitious Growth Targets,

Cosmos Health Ventures into U.S. Nutraceuticals Market with Sky Premium Life Brand, Anticipates Robust Financial Growth London, UK - Cosmos Health, a burgeoning player in the global health and wellness industry, has officially commenced its operations in the United States, targeting the lucrative $164 billion nutraceuticals market with its flagship brand,...

Sep 22, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Business Update
McKesson Restructures for Strategic Growth Amidst Rising Costs and Supplier Pressures

In a decisive move to streamline operations and bolster its competitive positioning, McKesson Corporation (NYSE: MCK) recently unveiled a new organizational structure, set to take effect in the second quarter of fiscal year 2026. This significant shift reflects McKesson s commitment to enhancing strategic alignment and improving transparency within its re...

Sep 19, 2025 • Pharmacy Services and Retail Drugstore Industry
MCK
Contract
Navigating the GCC Nutraceuticals Landscape Cosmos Healths Strategic Foray into Oman

In an ambitious stride into an effervescent market, Cosmos Health Inc. (NASDAQ: COSM) has expanded its presence within the Gulf Cooperation Council s (GCC) burgeoning nutraceuticals sector, signing a pivotal distribution agreement with Scientific Pharmacy in Oman. This strategic partnership heralds the launch of the Sky Premium Life product line, aligning...

Sep 11, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Announcement
Legal Whirlwind for PetMed Express Investors Navigate Uncharted Waters

In recent weeks, PetMed Express, Inc. (NASDAQ: PETS), a leading player in the online pet pharmacy space, has found itself at the center of a legal investigation led by the Pomerantz Law Firm. The firm, renowned for its focus on corporate governance and securities fraud, is currently investigating the potential claims on behalf of investors in PetMed Expre...

Aug 1, 2025 • Pharmacy Services and Retail Drugstore Industry
PETS
Business Update
A Prescription for Change Walgreens Shareholders Back Sycamore Partners Merger with Landslide Vote

In a move that signals a significant shift in the landscape of retail pharmacy, Walgreens Boots Alliance, Inc. (Nasdaq: WBA) shareholders have decisively approved the company s acquisition by entities affiliated with Sycamore Partners Management, L.P. At the special shareholders meeting, an overwhelming 96% of votes cast were in favor of the transaction, ...

Jul 12, 2025 • Pharmacy Services and Retail Drugstore Industry
WBA
Product Service News
Skys the Limit Cosmos Health Soars with Strong UAE Demand,

The Sky s the Limit: Cosmos Health Gains Momentum with New UAE Order In a promising expansion of its footprint in the health and wellness sector, Cosmos Health Inc. has secured a substantial follow-up order from Pharmalink for 80,000 units of its Sky Premium Life products in the United Arab Emirates. This comes on the heels of an impressive initial o...

May 7, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Partnership
In a significant stride towards enhancing the landscape of pet healthcare, PetMed Express, Inc. a leading ...

Bridging the Gap: PetMed Express, Inc. and Dutch Partner to Revolutionize Telehealth in Pet Care In a significant stride towards enhancing the landscape of pet healthcare, PetMed Express, Inc. a leading provider of prescription and non-prescription pet medications, has announced a groundbreaking partnership with Dutch, a pioneering telehealth service for...

May 7, 2025 • Pharmacy Services and Retail Drugstore Industry
PETS
Business Update
Guardian Pharmacy Services Expands Footprint in the Heart of Ohio A Commitment to Long-Term Care

In a significant development for the aging populations of Ohio, Kentucky, and West Virginia, Guardian Pharmacy Services, Inc. in partnership with Mullaney’s Pharmacy, has officially opened a new location in Columbus, Ohio. This strategic move marks a pivotal expansion in Guardian’s longstanding commitment to enhancing the quality of pharmaceutical car...

Apr 15, 2025 • Pharmacy Services and Retail Drugstore Industry
GRDN
Product Service News
Cosmos Health Accelerates Growth with Facility Upgrades and Strategic Partnership for AMBITASOL Production

In a strategic move aimed at bolstering its operational capabilities, Cosmos Health is making significant strides in both its manufacturing infrastructure and product development portfolio. The company has recently expanded its facility upgrade program at Cana Laboratories, a decision that underscores its commitment to enhancing operational efficiency and...

Apr 10, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Product Service News
Cosmos Healths Sky Premium Life Shoots for Success in Albania with Robust $300,000 Pharma Cell Partnership,

Cosmos Health, a renowned company with a solid standing in the healthcare industry, has strategically expanded its premium product line, Sky Premium Life, into the Albanian market. This expansion is facilitated through a pivotal partnership with Pharma Cell, a respected distributor known for its robust market presence and extensive distribution network ac...

Apr 9, 2025 • Pharmacy Services and Retail Drugstore Industry
COSM
Business Update
McKessons Strategic Acquisition A New Era in Ophthalmology and Financial Resilience

In a significant move to bolster its position in the healthcare sector, McKesson Corporation has completed its acquisition of a controlling interest in PRISM Vision Holdings, LLC, a prominent provider of general ophthalmology and retina management services. This acquisition, valued at approximately $850 million, reflects McKesson s strategic intent to exp...

Apr 2, 2025 • Pharmacy Services and Retail Drugstore Industry
MCK
Announcement
Balancing the Scales Walgreens Boots Alliance Navigates Legal and Market Challenges in 2025,

Balancing the Scales: Walgreens Boots Alliance Faces Legal Battles and Market Challenges In a complex weave of litigation and market dynamics, Walgreens Boots Alliance, Inc. (WBA) finds itself at a crucial crossroads. As investors scramble to meet a pivotal legal deadline, the company grapples with revenue growth challenges that have led to a dip in marke...

Mar 28, 2025 • Pharmacy Services and Retail Drugstore Industry
WBA
Announcement
Walgreens Boots Alliance Under Fire Class Action Lawsuit Emerges Amidst Declining Market Performance and Competitiv...

In a troubling turn of events for shareholders, Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is now at the center of a class action lawsuit, raising questions about the company s financial health and market positioning. Announced on March 3, 2025, The Gross Law Firm has issued a notice inviting shareholders who believe they have incurred losses to join th...

Mar 3, 2025 • Pharmacy Services and Retail Drugstore Industry
WBA
Announcement
for PublicationWalgreens Faces Legal Storm Class Actions Signal Big Business Reckoning for Investors,

Understanding the Legal Maze: Walgreens Boots Alliance Faces New Class Action Lawsuit for Aggrieved Investors In a recent development that has captured the attention of investors and legal experts alike, Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a leading name in the pharmaceutical retail industry, finds itself at the center of a significant legal bat...

Feb 24, 2025 • Pharmacy Services and Retail Drugstore Industry
WBA
Announcement
Walgreens Boots Alliance Faces Class Action as Financial Performance Signals Uneven Recovery Amid Market Ch...

Examining Walgreens Boots Alliance s Financial Landscape Amid Class Action Concerns In a notable development within the financial and corporate world, Levi and Korsinsky, LLP has announced that shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) should come forward before March 31, 2025, to discuss their rights concerning a class action securitie...

Feb 21, 2025 • Pharmacy Services and Retail Drugstore Industry
WBA
Business Update
Navigating Growth Waters How McKessons Strategic Realignment Is Rocketing Its Market Stature,

McKesson s Strategic Shift: Divesting Some, Growing MoreOn December 30, 2024, McKesson Corporation, a leading name in healthcare services and information technology, finalized the sale of its Canadian subsidiaries, Rexall and Well.ca, to Birch Hill Equity Partners. This move, initially announced in September, signifies a strategic pivot for McKesson, all...

Jan 4, 2025 • Pharmacy Services and Retail Drugstore Industry
MCK
Business Update
McKesson Corporation Streamlines Operations with Strategic Divestitures and Acquisitions in Oncology Sector

In a significant move to sharpen its operational focus and capital allocation, McKesson Corporation (NYSE: MCK) has completed the divestiture of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a prominent Canadian private equity firm. Announced in September 2024 and finalized on December 30, 2024, this strategic transaction i...

Jan 4, 2025 • Pharmacy Services and Retail Drugstore Industry
MCK
Business Update
Prescription for Change McKessons Strategic Leap from Retail to Oncology,

McKesson s Bold Pivot: From Rexall to Oncology Is It the Right PrescriptionIn a strategic move set to reshape its focus, McKesson Corporation has formally divested its Canada-based Rexall and Well.ca businesses, sealing the deal with Birch Hill Equity Partners on December 30, 2024. This transaction marks another chapter in McKesson’s ongoing evolution w...

Jan 4, 2025 • Pharmacy Services and Retail Drugstore Industry
MCK
Business Update
Nu Skin Ventures $250 Million Deal Sells Mavely to Later to Enhance Digital Marketing Portfolio,

Nu Skin Enterprises Sells Mavely Affiliate Marketing Platform in $250 Million Transaction with Later Nu Skin Enterprises Inc. (NYSE: NUS), a global personal care and wellness company based in Provo, Utah, has announced a significant strategic move involving its Rhyz Inc. subsidiary. The company completed the sale of its Mavely affiliate marketing technolo...

Jan 3, 2025 • Pharmacy Services and Retail Drugstore Industry
NUS
Business Update
Guardian Pharmacy Expands Reach in New Jersey Through Partnership with Freedom Pharmacy

In a notable development in the long-term care pharmacy sector, Guardian Pharmacy Services, publicly listed under NYSE: GRDN, has announced its expansion into New Jersey. This move is facilitated by a strategic partnership with Freedom Pharmacy, a well-regarded long-term care pharmacy. This expansion signifies a growing trend towards increasing accessibil...

Dec 17, 2024 • Pharmacy Services and Retail Drugstore Industry
GRDN
Stock Market Announcement
PetMed Express Secures Future with Protective Shareholder Measures and Strategic Executive Appointments,

PetMed Express Implements Shareholder Rights Plan and Inducement Grant to Secure Growth and WorkforceBy Delray Beach, Fla. - Dec. 3, 2024 - In a strategic move designed to bolster corporate governance and attract industry talent, PetMed Express, Inc. (dba PetMeds), and its subsidiary, PetCareRx, have announced significant measures that reflect the company...

Dec 3, 2024 • Pharmacy Services and Retail Drugstore Industry
PETS
Business Update
Guardian Pharmacy Services, Inc. Reports Strong Q3 2024 Financial Growth Driven by Strategic Expansion and Robust Org...

Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results ATLANTA Guardian Pharmacy Services, Inc. (Guardian) (NYSE: GRDN), one of the nation’s preeminent providers of long-term care (LTC) pharmacy services, has unveiled its financial results for the third quarter of 2024, showcasing impressive performance benchmarks for the period...

Nov 13, 2024
GRDN
Business Update
Cencora Expands Specialty Leadership Through Strategic Acquisition of Retina Consultants of America,

Cencora, Inc. (NYSE: COR), a renowned player in the healthcare services sector, has recently announced its definitive agreement to acquire Retina Consultants of America (RCA). RCA, a leading management services organization (MSO) specializing in retina care, stands poised to enhance Cencora s landscape with its robust network and specialized expertise. Th...

Nov 6, 2024 • Pharmacy Services and Retail Drugstore Industry
COR
Merger and Acquisition
PetIQ, Inc. and Bansk Group Join Forces in $1.5 Billion Acquisition to Deliver New Innovations in Pet Health and Wellness,

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group: A New Era for Pet Health and WellnessEAGLE, Idaho and NEW YORK, Oct. 25, 2024 – In a significant development that promises to reshape the landscape of pet healthcare, PetIQ, Inc. (PetIQ or the Company) has successfully completed its acquisition by Bansk Group, a consumer-focused...

Oct 25, 2024 • Pharmacy Services and Retail Drugstore Industry
PETQ
Merger and Acquisition
PetIQ, Inc. Secures Stockholder Approval for $1.5 Billion Merger with Bansk Group, Paving the Way for a New Era in Pet Healthcare,

In a significant development for the pet healthcare sector, PetIQ, Inc. a leading pet health and wellness company, announced that its merger agreement with Bansk Group has been officially approved by stockholders. This approval comes after a special meeting held on August 7, 2024, where shareholders overwhelmingly backed the $1.5 billion acquisition. PetI...

Oct 22, 2024 • Pharmacy Services and Retail Drugstore Industry
PETQ
Shares
PetMed Express Seeks Stability with New Executive Grants Amid Investor Concerns,

PetMed Express Awards Equity Grants Amidst Investor Scrutiny and Fluctuating Market ConditionsDelray Beach, Fla. PetMed Express, Inc. (Nasdaq: PETS), the well-known online pet pharmacy operating under the brand name PetMeds and the parent company of PetCareRx, recently announced the granting of two equity awards to newly hired executives. This decision ...

Sep 27, 2024 • Pharmacy Services and Retail Drugstore Industry
PETS
Management Announcement
Cardinal Health's Partnership with Telix Pharmaceuticals: A Potential Win Amid Tumultuous Stock Performance,

Cardinal Health s New Role as Distributor for Telix Pharmaceuticals Sparks Mixed Sentiments Amid Stock Struggles<br/>In a strategic move poised to bolster its market position, Telix Pharmaceuticals Limited recently announced Cardinal Health, Inc. as the U.S. commercial distributor for its innovative radiopharmaceutical product, Zircaix (TLX250-CDx), int...

Sep 17, 2024 • Pharmacy Services and Retail Drugstore Industry
CAH

Decision Framework & Data Access

Power onboarding, benchmarking, and quantitative analysis with institutional-grade datasets structured for direct integration into financial models and risk frameworks.

  • Industry benchmarking datasets (valuation, growth, profitability)
  • Designed for quant models, AML/KYC validation & onboarding workflows
  • Consistent time-series structure (Quarterly, TTM, Annual)
  • Coverage across 100+ industries and 20+ years of history
CSV - SFTP - REST API - Daily Updates - Integration-ready for Python, R & BI tools